“Imagine if fewer people suffered and died from cancer because we detected and diagnosed the disease or its precursors at the earliest possible stage.” — National Cancer Institute

Optinosis, Inc.

6470 E Johns Crossing

Suite 160 PMB 1038

Johns Creek, GA 30097

email: [email protected]

Our Opportunity

Cancer is the leading cause of death across the globe. And, it’s growing:

2024 will be the first year that new cancer diagnoses exceed 2M in the U.S.1

Annual global cancer diagnoses are expected to rise to 29.9M by 2040.2

U.S. cancer expenditures were $208.9B in 2020 and are trending up as the U.S. population ages.3

Our Mission

Together, We Can Lower Healthcare Costs and Improve Patient Outcomes.

Treating metastatic cancers can lead to 7 times higher costs than treating early-stage cancers.4

Early diagnosis across 19 cancers could result in an estimated $26 billion cost-savings, representing about 17% of the direct costs related to cancer treatment.5